Permeability pathways of Ca2+ efflux from mitochondria: H+ specificity and reversibility of the permeability defect.
Pfeiffer
D R
DR
Hormel Institute, University of Minnesota, Austin 55912.
Broekemeier
K M
KM
Igbavboa
U
U
Reers
M
M
Riley
W W
WW
D000818:Animals; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism* / Q000494:pharmacology; D004533:Egtazic Acid / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D007425:Intracellular Membranes / Q000378:metabolism; D007700:Kinetics; D008246:Lysophospholipids / Q000378:metabolism; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism*; D008933:Mitochondrial Swelling / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D010539:Permeability; D010545:Peroxides / Q000494:pharmacology; D051381:Rats; D020122:tert-Butylhydroperoxide
D008246:Lysophospholipids; D010545:Peroxides; C008301:lysophosphatidylethanolamine; D000001:Calcimycin; D004533:Egtazic Acid; D020122:tert-Butylhydroperoxide; D002118:Calcium